Patet C. et al:
Efficacy of the separprocathTM radiation drape to reduce the radiation exposure during cardiac catheterization: a pilot comparative study.
In print: In Cardiovascular and Cardiovascular Interventions.
The development of cardiac catheterization procedures has been associated with increasing numbers of radiation-induced diseases in the medical staff, ranging from "benign" subcapsular cataracts to a presumed higher risk of malignancies. Interventional cardiologists and room staff are exposed to two main sources of radiation:x-ray tube leakage and scatter radiation from the patient.
SEPARPROCATHTM was associated with a lower operator radiation exposure corresponding to a RE relative risk reduction of 81% and 99% respectively. Similar reductions were observed for operator and nurse cumulative doses. No difference was found in Dose Area Product.
We sought to compare the radiation exposure (RE) of the cardiac catheterization room staff using SEPARPROCATHTM, a novel radio-protective drape versus standard shielding equipment.
SEPARPROCATHTM is a novel, lead-free, radioprotection drape, that significantly decreases radiation exposure of the medical staff during cardiac catheterization procedures while guaranteeing patient safety.
Efficacy of the SEPARPROCATH® radiation drape to reduce radiation exposure during cardiac catheterization:
A pilot comparative study
Camille Patet MD1 | Nick Ryckx PhD2 | Diego Arroyo MD1 | Stéphane Cook MD1 | Jean-Jacques Goy FESC, MD1, 3
Certification d’enregistrement de la marque de commerce – Office de la propriété Intellectuelle du Canada
Surgical drape including a layer to protect the operator from scattered radiation during cardiologic and radiologic invasive procedures
Radiation Exposure of the Operator During Coronary Interventions (from the RADIO Study)
United States Patent
Enregistrement de la marque de commerce au United States Patent and Trademark Office